UNASSIGNED: The purpose of this study was to determine if the Entonox gas could cause adequate analgesic and sedative effects in @entity1 who need cardioversion. In this randomized not blinded clinical trial, the sedative and analgesic effects of @entity1363 and @entity3575 were compared with Entonox. Eligible @entity1 who need synchronized cardioversion because of @entity943 were randomly divided into two groups. The first group received intravenous @entity1363 and @entity3575 ; the second group received Entonox through a blower-dependent mask. Onset and end of sedation, sedation level, and @entity158 score were recorded. There were nonsignificant differences between the two groups (22 @entity1 in each group) regarding age, gender, weight, sedation level, and frequency and level of shock. The @entity158 score recorded in the first group was 5.05    1.32, and 3.9    0.7 in the second group (P = 0.002). Furthermore, sedation duration and time to full recovery consciousness were shorter in the second group (P < 0.001). In the first group, seven @entity1 needed additional doses to induce and maintain sedation. In addition, as a result of apnoea, four @entity1 required airway support. None of them occurred in the second group. Entonox is a suitable medication in rapid cardioversion, as it has minimal side effects and adequate analgesic and sedative effects.

Sedative and Analgesic Effects of Entonox Gas Compared with @entity1363 and XXXX in Synchronized Cardioversion.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity158 :: ('MESH:D010146', 'Disease') :: ['pain'] @entity1363 :: ('MESH:D008874', 'Chemical') :: ['midazolam'] @entity943 :: ('MESH:D001145', 'Disease') :: ['dysrhythmia'] @entity3575 :: ('MESH:D005283', 'Chemical') :: ['fentanyl']
@entity3575 :: (MESH:D005283,Chemical) :: ['Fentanyl']
